Ceva's Vetrimoxin®LA: First Line Reference16 May 2014
FRANCE - Ceva is committed to promoting the responsible use of antibiotics by professionals, veterinarians and pharmacists who in turn work with farmers and owners of companion animals across the world.
To support their work Ceva provides a wide range of anti-infective molecules, improved formulations, unique packaging (CLAS), efficient treatment systems and professional training programmes which improve compliance across all farm sizes and field environments.
Ceva, among its wide range of injectable antiinfectifes, offers Vetrimoxin LA: 150mg per ml suspension for injection in cattle and pigs (long-action amoxicillin) for the treatment of affections caused by susceptible organisms, and more particularly respiratory affections, neonatal diseases, etc.
Vetrimoxin LA is the leader injectable amoxicillin in the animal health sector worldwide. Presented in its specific CLAS® container, patented by Ceva, Vetrimoxin LA is a unique specialty that provides at the same time a quick and long lasting efficiency as well as good comfort for the pig and for the farmer.
The injectable suspension of Vetrimoxin LA is produced in the specialised unit certified as GMP site in Ceva industrial plant in Libourne, France. To ensure the highest quality of the injectable long acting amoxicillin, a sophisticated manufacturing process is implemented.
Vetrimoxin LA is indicated for the treatment and control of bacterial respiratory infections such as P. multocida, S. suis, A. pyogenes. Its broad spectrum efficacy, high peak Cmax and long activity predispose Vetrimoxin LA to being the first choice product for the treatment of such mixed infections.
Vetrimoxin LA, as the leading injectable amoxicilline, is the reliable preferred partner in the daily veterinarian activity to treat important pathologies which can impact on the animal’s health and affect the husbandry performances, thanks to its convenient withdrawal period, re-suspension, syringeability and its broad spectrum of action.
|ThePigSite News Desk|